Similar results of robotic and uniportal videothoracoscopic surgery for lung cancer treatment

Veronesi, Giulia; Bonovas, Stefanos

doi:10.21037/jtd.2018.03.88

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other technically complex resections, such as sleeve resection or pneumonectomy, can also be safely completed via a robotic platform. There are numerous tangible advantages to the robotic platform, such as lower overall complication rate, less blood loss, decreased postoperative pain, shorter length of stay, as well as optimized pathologic staging due to a more complete lymph node dissection in comparison to thoracotomy ( 3 ). In a large multi-center study with 1,336 robotic lobectomies performed, Cerfolio et al demonstrates median blood loss of 50 ml, mean operative time of 136 min, and median length of stay of 3 days ( 4 ), all of which have improved over the past 2 years (publication pending).…”

Section: Introductionmentioning

confidence: 99%

Extended Robotic Pulmonary Resections

et al. 2021

View full text Add to dashboard Cite

While lung cancer remains the most common cause of cancer-related mortality in the United States, surgery for curative intent continues to be a mainstay of therapy. The robotic platform for pulmonary resection for non-small cell lung cancer (NSCLC) has been utilized for more than a decade now. With respect to more localized resections, such as wedge resection or lobectomy, considerable data exist demonstrating shorter length of stay, decreased postoperative pain, improved lymph node dissection, and overall lower complication rate. There are a multitude of technical advantages the robotic approach offers, such as improved optics, natural movement of the operator's hands to control the instruments, and precise identification of tissue planes leading to a more ergonomic and safe dissection. Due to the advantages, the scope of robotic resections is expanding. In this review, we will look at the existing data on extended robotic pulmonary resections, specifically post-induction therapy resection, sleeve lobectomy, and pneumonectomy. Additionally, this review will examine the indications for these more complex resections, as well as review the data and outcomes from other institutions' experience with performing them. Lastly, we will share the strategy and outlook of our own institution with respect to these three types of extended pulmonary resections. Though some controversy remains regarding the use and safety of robotic surgery in these complex pulmonary resections, we hope to shed some light on the existing evidence and evaluate the efficacy and safety for patients with NSCLC.

show abstract

Section: Introductionmentioning

confidence: 99%